A Newcastle-based biotech company is set to expand its innovative lab testing services after raising £750,000 in funding. Aelius Biotech, founded in 2018 by Dr Peter Chater, Dr Matt Wilcox and ...

A Newcastle biotech company is set to expand its overseas presence after raising a further £750,000. Aelius Biotech’s laboratory gut model is used to trial new drugs and foodstuffs without the need ...

Ballast Book Company opened in 2015, when Suzanne Droppert—then the owner of Liberty Bay Books in Poulsbo, Wash.—wanted to try selling books in nearby Bremerton. “We opened as a pop-up, and ...

With six table tennis facilities now thriving in Mukuru Kwa Njenga and Kariobangi, Vision Changers Kenya has shown how sport can spark social transformation from the grassroots up. The youths were ...

The funding will help Aelius Biotech to expand its presence in the US and European markets and complete work on its new laboratory in Newcastle's Blandford Square. It has been secured from the North ...

DULUTH — Proposed changes to federal Medicaid funding could result in $880 billion in cuts over 10 years. During a Sunday "Face the Nation" interview on CBS, House Budget Committee Chairman Rep.

The Senate has advanced a budget blueprint that calls for significantly lower spending cuts than its House counterpart, setting the bodies up for a clash in reconciling the two plans as the ...

Aelius Biotech’s laboratory gut model is used to trial new drugs and foodstuffs without the need for animal testing, with its model showing how substances will be digested by the body ...

If import purchases stayed the same, that would raise the tariff bill to about $960 billion, making it an $880 billion tax hike paid by American businesses and consumers.

With its advanced design, innovative features and improved weight, the PK 880 TEC is perfectly suited for operation in confined spaces,” says Alexander Susanek, COO at PALFINGER.

VX-880 (formerly known as STx-02) derives from Vertex’ near $1 billion acquisition of Semma in 2019, and has started enrolling patients in a phase 1/2 study in the US. The therapy takes the form ...